Figure 2From: KRAS and the Reality of Personalized Medicine in Non-Small Cell Lung CancerKRAS-related pathways. Targeted agents for pathogenic mutations involved in NSCLC are shown. (Comprehensive information available at: https://mycancergenome.org.)Back to article page